Hyloris Pharmaceuticals Employee Directory
Biotechnology ResearchWallonia, Belgium51-200 Employees
Hyloris Pharmaceuticals is a Belgium-based specialty pharmaceutical and biotechnology company focused on reinventing existing medicines through reformulation and repurposing, with selective development of new chemical entities to address unmet health needs. Its development strategy leverages established regulatory pathways, such as the FDA 505(b)(2) route, to shorten timelines and reduce development risk. The company reports a pipeline of more than 30 products, including 28 in development and 25 value-added medicines, with two in early commercialization with commercial partners. Hyloris has two high-barrier generics approved in the U.S. and one more in development, and is based in Liège, Wallonia, Belgium, with listing on Euronext Brussels since 2020. A notable recent development is an exclusive worldwide development and commercialization licensing agreement with RedHill Biopharma for RHB-102 Bekinda, excluding North America, announced in 2025.
1-888-653-2347 
support@leadiq.com 
